Procurement Summary
Country : Brazil
Summary : The Object of this Public Notice is the Auction for Price Registration, Aiming at Future and Possible Acquisition of Medicines Case Group 2 (No Demand Part 2) - Annual Plan 2023, According to Specifications...
Deadline : 24 Nov 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 74459513
Document Ref. No. : 369/2022
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - The object of this notice is the Auction for Price Registration, aiming at future and possible ACQUISITION OF MEDICINES CASE GROUP 2 (WITHOUT DEMAND PART 2) - ANNUAL PLAN 2023, according to the detailed specifications contained in this Notice in the attached table
UASG code: 9492584800e8c8d91eb93b064ebe674eb26775
Notice from: 11/09/2022 from 08:00 to 13:00h and from 14:00 to 17:00h
Delivery of the Proposal: from 11/09/2022 to 08:00h
MESALAZINE, 800 MG CONCENTRATION
Quantity: 4764
MESALAZINE, 1G CONCENTRATION, PHARMACEUTICAL FORM GRANULE ORAL USE, PROLONGED RELEASE
Quantity: 1488
TARGET67d73f7cdfbc6b97a3398f07d475a1feDONA, DOSAGE 10 MG
Quantity: 1000
METHADONE, DOSAGE 10 MG/ML, USE FOR INJECTABLE SOLUTION
Quantity: 1488
METHYLPREDNISOLONE, ACTIVE PRINCIPLE SUCCINAL SALT, DOSAGE 500 MG, PRESENTATION LYOPHYLIZED POWDER DILUENT, INJECTABLE
Quantity: 168
MORPHINE, PRESENTATION SULFATE, 100MG CONCENTRATION, PHARMA FORM67d73f7cdfbc6b97a3398f07d475a1feSCEUTICAL SCHEDULED RELEASE
Quantity : 1000
MORPHINE, SULFATE PRESENTATION, 60MG CONCENTRATION, PHARMACEUTICAL FORM SCHEDULED RELEASE
Quantity : 300
MORPHINE, SULFATE PRESENTATION, 30MG CONCENTRATION, PHARMACEUTICAL FORM SCHEDULED RELEASE
Quantity: 1000
MORPHINE, SULFATE CONCENTRATION, SULPHATE PRESENTATIONCENTRATION 60MG, PHARMACEUTICAL FORM SCHEDULED RELEASE
Quantity: 1000
NAPROxENE, DOSAGE 250MG
Quantity: 2232
NAPROxENE, DOSAGE 500MG
Quantity: 1116
PRAVASTATIN, DOSAGE 10MG
Quantity: 1488
PRAVASTATIN, DOSAGE 40 MG
PRAVASTATIN, DOSAGE 40MG
Quantity: 372
PR67d73f7cdfbc6b97a3398f07d475a1feIMIDONE, DOSAGE 250 MG
Quantity: 10800
TIMOLOL, COMPOSITION ASSOCIATED WITH BRIMONIDINE AND BIMATOPROST, CONCENTRATION 0.5% 0.15% 0.01%, PHARMACEUTICAL FORM OPTALMIC SOLUTION
Quantity: 1000
DAPAGLIFLOZIN, CONCENTRATION 5 MG
Quantity: 600067d73f7cdfbc6b97a3398f07d475a1fe
Documents
Tender Notice